Global Cataract Surgery Devices Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, By Product Type (Intra-ocular Lenses (IOL), Phacoemulsification Systems, Standard Phaco Machines, Advanced Phaco Machines, Ophthalmic Viscoelastic Devices, Femtosecond Laser Systems, Others (Knives and Low-Cost Consumables)), By Surgery Technique (Manual Small-Incision Cataract Surgery, Phaco-based Standard Surgery, Femtosecond-Laser-Assisted Cataract Surgery (FLACS), Others (Extracapsular Cataract Extraction, Intracapsular Cataract Extraction, and Micro-Incision Cataract Surgery)), By End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers, Academic and Research Institutes), By Region, By Company 2021-2031F 2021-2031F

Key Insights	Details
Forecast Period	2026 - 2031
Market Size (2025)	USD 8.86 Billion
CAGR (2026-2031)	4.2%
Fastest Growing Segment	Femtosecond-laser-assisted cataract surgery (5.73% CAGR to 2031)
Largest Market	North America
Market Size (2031)	USD 11.34 Billion

Market Overview

The Global Cataract Surgery Devices Market is expected to grow from USD 8.86 Billion in 2025 to USD 11.34 Billion by 2031 at a 4.2% CAGR. Cataract surgery devices encompass the specialized instruments, equipment, and consumables essential for the surgical removal of cataracts and subsequent implantation of intraocular lenses. The market for these devices is primarily driven by the escalating global aging population and the increasing prevalence of cataracts. Furthermore, the rising incidence of lifestyle disorders such as diabetes, which contribute to cataract formation, alongside improved access to ophthalmic care in developing nations, significantly propel market growth. According to the World Health Organization, in February 2026, cataract affected more than 94 million people globally.

Despite these robust growth drivers, a significant challenge impeding market expansion is the persistent issue of limited access to surgical care, particularly in low-income regions. This disparity is often attributed to inadequate healthcare infrastructure, a shortage of trained ophthalmic personnel, and considerable out-of-pocket costs for patients. According to the World Health Organization, in February 2026, nearly half of all individuals worldwide requiring cataract surgery still lacked access to the procedure.

Key Market Drivers

Aging Population Drives Demand for Cataract Devices
The increasing global aging population represents a fundamental driver for the cataract surgery devices market, as cataracts are predominantly age-related. As individuals live longer, the cumulative exposure to risk factors for cataract development increases significantly. This demographic shift directly translates into a larger pool of potential patients requiring surgical intervention, thereby stimulating demand for a range of devices, including phacoemulsification systems and various intraocular lenses. For instance, according to the U.S. Census Bureau, in August 2026, in the 'An Aging World: 2025' report, the share of the world population aged 65 and older is projected to nearly double from 10.5% to 19.6% between 2025 and 2060. This demographic expansion necessitates a corresponding growth in the availability and sophistication of cataract surgery devices to meet rising healthcare needs worldwide.

Advancements in Cataract Technology Drive Growth
Technological advancements in cataract surgery devices are another critical factor propelling market expansion, offering enhanced precision, improved patient outcomes, and reduced recovery times. Innovations in intraocular lens (IOL) design, such as toric, multifocal, and extended depth of focus IOLs, provide patients with premium vision correction options, increasing their willingness to undergo surgery. Similarly, the evolution of femtosecond laser-assisted cataract surgery and more advanced phacoemulsification platforms contributes to higher procedural efficiency and safety. According to Alcon, in June 2026, in its '2025 Social Impact & Sustainability Report', the company invested more than $990 million in research and development in 2025. Furthermore, according to Contact Lenses, in 2026, approximately 28 million cataract procedures are performed annually worldwide. These advancements not only attract new patients but also encourage wider adoption of modern surgical techniques and associated device sales.

Download Free Sample Report

Key Market Challenges

Access constraints hamper market growth.
The persistent challenge of limited access to surgical care significantly constrains the growth of the global cataract surgery devices market. This access disparity stems from multiple factors, including insufficient healthcare infrastructure, a critical shortage of trained ophthalmic personnel, and substantial out-of-pocket costs for patients. When individuals cannot access necessary surgical procedures, the demand for essential specialized instruments, equipment, and consumables required for those surgeries is directly suppressed.

Low surgical volumes suppress device sales and adoption.
This situation directly impedes market expansion by reducing the overall volume of procedures performed. According to the International Agency for the Prevention of Blindness, in January 2026, cataract surgery rates in many low and middle-income countries were reported to be fewer than 1,000 operations per million population annually, sharply contrasting with rates exceeding 5,000 operations per million in high-income nations. Furthermore, the estimated effective cataract surgical coverage in the African region stood at merely 23.6% in 2025. Such low surgical volumes in large populations directly translate to diminished sales and adoption of cataract surgery devices, thereby directly hampering market growth.

Key Market Trends

Shift to Ambulatory Surgical Centers Drives Outpatient Cataract Device Demand
The global cataract surgery devices market is currently shaped by a notable shift towards outpatient and ambulatory surgical centers for procedures. This trend is driven by several factors, including cost-efficiency, patient convenience, and favorable reimbursement policies that support the migration of eligible surgical cases from traditional hospital settings. These specialized facilities streamline surgical workflows and reduce overhead, making cataract surgery more accessible and often more affordable. For instance, according to an article in Ophthalmology Management, March 2026, the finalized 2026 Ambulatory Surgical Center (ASC) facility rate for routine cataract surgery codes CPT 66982 and 66984 was set at $1,255.73, representing a 3.4% increase over the prior year’s payment, underscoring policy support for these settings. This increasing preference for ASCs influences demand for compact, efficient, and high-throughput cataract surgery devices designed for outpatient environments.

AI-Driven Advances in Cataract Surgery Planning and Intraoperative Guidance
Another significant trend impacting the market is the integration of artificial intelligence (AI) in surgical planning and guidance. AI is rapidly moving beyond theoretical applications to become a practical tool in ophthalmology, offering enhanced precision and personalized patient outcomes. In cataract surgery, AI-powered systems are utilized for advanced intraocular lens (IOL) power calculations, preoperative risk assessment, and real-time intraoperative guidance, leading to improved refractive accuracy. According to the Eye Care Network, December 2025, a recent survey revealed that ophthalmologists identified AI as the "most transformative trend in ophthalmology," with 78% of respondents citing it as such. This strong endorsement highlights the growing confidence in AI's ability to augment surgeon capabilities, optimize decision-making, and contribute to the development of more sophisticated cataract surgery devices.

Segmental Insights

Femtosecond-Laser-Assisted Cataract Surgery: Fastest-Growing Segment
The Global Cataract Surgery Devices Market observes Femtosecond-laser-assisted cataract surgery as its most rapidly expanding segment, driven by superior surgical precision and enhanced patient outcomes. This advanced technology leverages computer-guided lasers to perform critical steps, including corneal incisions and capsulotomies, with exceptional accuracy that surpasses conventional manual methods. The procedure also offers a better safety profile by minimizing trauma to ocular tissues and reducing the required ultrasound energy, thereby leading to fewer complications and accelerating postoperative recovery. Furthermore, the capability to precisely correct astigmatism concurrently contributes significantly to its increasing adoption and surgeon preference.

Regional Insights

North America Drives Market Leadership: Infrastructure, Demographics, Reimbursement, and Innovation
North America leads the global cataract surgery devices market, primarily due to its sophisticated healthcare infrastructure and established ophthalmology centers. The region experiences a significant prevalence of cataracts, particularly within its aging demographic, which directly contributes to high surgical volumes. Favorable reimbursement policies and comprehensive insurance coverage, including programs like Medicare Part B in the United States, facilitate patient access to advanced procedures and devices. This dominance is further strengthened by the strong adoption of innovative technologies, such as premium intraocular lenses and femtosecond lasers, along with a robust regulatory environment supported by bodies like the U.S. Food and Drug Administration, which fosters continuous technological advancements.

Recent Developments

• In October 2025, Horizon Surgical Systems completed the world's first robotic-assisted cataract surgery using its Polaris platform. This breakthrough research milestone demonstrated the system's precision, consistency, and efficiency, leveraging micro-robotics and AI-supported technology specifically for ophthalmology. The Polaris platform, designed to extend surgeons' capabilities rather than replace them, seeks to establish a new standard of safety and precision in eye surgery, addressing challenges such as variability in surgical outcomes and rising patient demand.
• In July 2025, BVI, a global ophthalmic device company, launched its new SERENITY IOLs featuring ISOFOCAL technology. These premium monofocal intraocular lenses were recognized for breakthrough innovation in ophthalmic implants, marking a significant product launch within the cataract surgery devices market. The introduction of the SERENITY IOL portfolio, representing the second generation of BVI's ISOPURE family, aims to further advance eye care technology and provide enhanced vision correction options for patients undergoing cataract procedures.
• In April 2025, Sightpath Medical announced a strategic collaboration with Custom Surgical Partners to facilitate office-based cataract surgery. This partnership aims to address the increasing demand for in-office procedures by offering a comprehensive, turnkey solution. Sightpath Medical contributes its mobile surgical services, while Custom Surgical Partners provides expertise in designing and managing office-based surgical suites. This initiative supports ophthalmologists in transitioning to and operating efficient in-office surgical environments, thereby expanding access to high-quality cataract care.
• In October 2024, ZEISS Medical Technology introduced the MICOR 700, a new lens extraction device for the cataract surgery market. This innovative handheld device operates without ultrasound, marking an advancement in lens removal technology. Designed for the ZEISS NULEX (non-ultrasonic lens extraction) procedure, the MICOR 700 aims to provide a gentler patient experience and expand surgical options. Its availability in the U.S. offers surgeons a sustainable solution for lens extraction with a low initial investment.

Key Market Players

• Alcon
• Johnson & Johnson
• Carl Zeiss
• Bausch + Lomb
• Nidek
• STAAR SURGICAL COMPANY
• HOYA
• EssilorLuxottica
• Ziemer Group
• HAAG-Streit

By Product Type	By Surgery Technique	By End User	By Region
Intra-ocular Lenses (IOL) Phacoemulsification Systems Standard Phaco Machines Advanced Phaco Machines Ophthalmic Viscoelastic Devices Femtosecond Laser Systems Others (Knives and Low-Cost Consumables)	Manual Small-Incision Cataract Surgery Phaco-based Standard Surgery Femtosecond-Laser-Assisted Cataract Surgery (FLACS) Others (Extracapsular Cataract Extraction, Intracapsular Cataract Extraction, and Micro-Incision Cataract Surgery)	Hospitals Ophthalmology Clinics Ambulatory Surgery Centers Academic and Research Institutes	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Cataract Surgery Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cataract Surgery Devices Market, By Product Type:

• Intra-ocular Lenses (IOL)
• Phacoemulsification Systems
• Standard Phaco Machines
• Advanced Phaco Machines
• Ophthalmic Viscoelastic Devices
• Femtosecond Laser Systems
• Others (Knives and Low-Cost Consumables)

• Cataract Surgery Devices Market, By Surgery Technique:

• Manual Small-Incision Cataract Surgery
• Phaco-based Standard Surgery
• Femtosecond-Laser-Assisted Cataract Surgery (FLACS)
• Others (Extracapsular Cataract Extraction, Intracapsular Cataract Extraction, and Micro-Incision Cataract Surgery)

• Cataract Surgery Devices Market, By End User:

• Hospitals
• Ophthalmology Clinics
• Ambulatory Surgery Centers
• Academic and Research Institutes

• Cataract Surgery Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE